Lv5
810 积分 2024-11-18 加入
Pseudoprogression in cancer immunotherapy: Rates, time course and patient outcomes
4天前
求助中
The efficacy of immune checkpoint inhibitors in patients with cancer with pseudoprogression
4天前
已关闭
Distinct CD8+ T cell dynamics associate with response to neoadjuvant cancer immunotherapies
21天前
已完结
CCR 20th Anniversary Commentary: Immune-Related Response Criteria—Capturing Clinical Activity in Immuno-Oncology
1个月前
已完结
Adaptation and modification of the immune related response criteria (IRRC): IrRECIST
1个月前
已完结
Adaptation and modification of the immune related response criteria (IRRC): IrRECIST
1个月前
已关闭
Immediate post-radiotherapy changes in malignant glioma can mimic tumor progression
1个月前
已完结
New Response Criteria Proposed for Immunotherapies
1个月前
已完结
A clinical development paradigm for cancer vaccines and related biologics
1个月前
已完结
皖公网安备34019202002308
